Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Operating Leases (2023 - 2025)

Historic Operating Leases for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to $5.7 million.

  • Beta Bionics' Operating Leases changed N/A to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year change of. This contributed to the annual value of $5.7 million for FY2024, which is 9093.03% up from last year.
  • Latest data reveals that Beta Bionics reported Operating Leases of $5.7 million as of Q3 2025.
  • Beta Bionics' 5-year Operating Leases high stood at $5.7 million for Q4 2024, and its period low was $3.0 million during Q4 2023.
  • Over the past 3 years, Beta Bionics' median Operating Leases value was $5.4 million (recorded in 2025), while the average stood at $5.0 million.
  • Within the past 5 years, the most significant YoY rise in Beta Bionics' Operating Leases was 9093.03% (2024), while the steepest drop was 9093.03% (2024).
  • Beta Bionics' Operating Leases (Quarter) stood at $3.0 million in 2023, then surged by 90.93% to $5.7 million in 2024, then fell by 0.33% to $5.7 million in 2025.
  • Its last three reported values are $5.7 million in Q3 2025, $5.2 million for Q2 2025, and $5.4 million during Q1 2025.